Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011:2011:815038.
doi: 10.4061/2011/815038. Epub 2011 Sep 11.

A systematic review of serum biomarkers anti-cyclic citrullinated Peptide and rheumatoid factor as tests for rheumatoid arthritis

Peter Taylor  1 , Juliane Gartemann, Jeanie Hsieh, James Creeden
Affiliations

A systematic review of serum biomarkers anti-cyclic citrullinated Peptide and rheumatoid factor as tests for rheumatoid arthritis

Peter Taylor et al. Autoimmune Dis. 2011.

Erratum in

  • Autoimmune Dis. 2012;2012:734069

Abstract

This systematic review assesses the current status of anti-cyclic citrullinated peptide (anti-CCP) and rheumatoid factor (RF) tests in the diagnosis and prognosis of rheumatoid arthritis (RA). We reviewed publications on tests and biomarkers for early diagnosis of RA from English-language MEDLINE-indexed journals and non-MEDLINE-indexed sources. 85 publications were identified and reviewed, including 68 studies from MEDLINE and 17 non-MEDLINE sources. Anti-CCP2 assays provide improved sensitivity over anti-CCP assays and RF, but anti-CCP2 and RF assays in combination demonstrate a positive predictive value (PPV) nearing 100%, greater than the PPV of either of the tests alone. The combination also appears to be able to distinguish between patients whose disease course is expected to be more severe and both tests are incorporated in the 2010 ACR Rheumatoid Arthritis Classification Criteria. While the clinical value of anti-CCP tests has been established, differences in cut-off values, sensitivities and specificities exist between first-, second- and third-generation tests and harmonization efforts are under way. Anti-CCP and RF are clinically valuable biomarkers for the diagnosis and prognosis of RA patients. The combination of the two biomarkers in conjunction with other clinical measures is an important tool for the diagnosis and management of RA patients.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Pathogenesis in rheumatoid arthritis and current diagnostic tools in use.
Figure 2
Figure 2
Literature retrieval strategy.
See this image and copyright information in PMC

References

    1. Rindfleisch JA, Muller D. Diagnosis and management of rheumatoid arthritis. American Family Physician. 2005;72(6):1037–1047. - PubMed
    1. Eustice C, Eustice R. Rheumatoid Arthritis—Fast Facts, 2008.
    1. Cannella AC, O’Dell JR. Early rheumatoid arthritis: pitfalls in diagnosis and review of recent clinical trials. Drugs. 2006;66(10):1319–1337. - PubMed
    1. Van Dongen H, Van Aken J, Lard LR, et al. Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: a double-blind, randomized, placebo-controlled trial. Arthritis & Rheumatism. 2007;56(5):1424–1432. - PubMed
    1. Orozco C, Olsen NJ. Identification of patients with early rheumatoid arthritis: challenges and future directions. Clinical and Developmental Immunology. 2006;13(2–4):295–297. - PMC - PubMed

LinkOut - more resources